6 completed, 3 unknown, 1 not yet recruiting, 1 terminated. 11 Phase 2, 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 11 | Completed 6, Unknown 3, Not yet recruiting 1, Terminated 1 |
| Phase 1 | 4 | Completed 1, Not yet recruiting 1, Terminated 1, Unknown 1 |
Follow Jaktinib: new trials by email Literature Review of Jaktinib trials Research Report on Jaktinib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Jaktinib for Steroid-Refractory Acute Graft-Versus-Host Disease Jaktinib - Acute Graft vs Host Disease | Phase 1 / Phase 2 | Not yet recruiting | Nanfang Hospital, Southern Medical University | 49 | 2026-10-10 | 2026-10-21 |
| A Study of Jaktinib for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease. Jaktinib Hydrochloride Tablets - Acute Graft-Versus-Host Disease | Phase 2 | Unknown | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 60 | 2024-12-01 | 2024-03-06 |
| Efficacy and Safety of Jaktinib in Patients With COVID-19 Pneumonia. Jaktinib, Placebo - COVID-19 Pneumonia | Phase 2 | Unknown | First Affiliated Hospital of Zhejiang University | 60 | 2023-03-01 | 2023-01-17 |
| Jaktinib and Azacitidine In Treating Patients With MDS With MF or MDS/MPN With MF. Jaktinib, azacitidine - Myelodysplastic Syndromes, Myeloproliferative Neoplasms | Phase 1 / Phase 2 | Terminated | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 1 | 2021-09-30 | 2022-12-01 |
| A Phase 2 Study of Jaktinib in Participants With Moderate to Severe Psoriasis Jaktinib, Placebo - Moderate-to-Severe Plaque Psoriasis | Phase 2 | Completed | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 123 | 2021-03-11 | 2025-02-20 |
| Clinical Study of Jaktinib in the Treatment of Patients With Moderate and Severe Atopic Dermatitis Jaktinib, placebo - Atopic Dermatitis | Phase 2 | Completed | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 166 | 2020-12-02 | 2023-03-24 |
| Jaktinib Hydrochloride Tablets In The Treatment of Active Ankylosing Spondylitis Jaktinib Hydrochloride Tablets, Placebo - Ankylosing Spondylitis | Phase 2 | Completed | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 108 | 2020-12-01 | 2023-03-29 |
| Jaktinib Hydrochloride Cream For Atopic Dermatitis Jaktinib Hydrochloride Cream, Placebo - Atopic Dermatitis | Phase 1 / Phase 2 | Completed | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 107 | 2020-10-14 | 2024-04-02 |
| Study of Jaktinib Hydrochloride Tablets in Participants With Idiopathic Pulmonary Fibrosis Jaktinib Hydrochloride Tablets, Placebo - Idiopathic Pulmonary Fibrosis | Phase 2 | Completed | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 91 | 2020-09-08 | 2024-12-12 |
| A Study With Jaktinib Hydrochloride Cream Applied Topically to Subjects With Alopecia Areata Jaktinib hydrochloride cream, Placebo - Alopecia Areata(AA) | Phase 1 / Phase 2 | Unknown | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 160 | 2020-08-12 | 2024-03-06 |
| Jaktinib for the Treatment of Ruxolitinib Intolerance of Myelofibrosis Jaktinib hydrochloride tablets - Primary Myelofibrosis (PMF), Post-polycythemia Vera Myelofibrosis(Post-PV MF) | Phase 2 | Completed | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 51 | 2020-01-07 | 2023-04-20 |
Dermatitis, Atopic (2) · Primary Myelofibrosis (2) · Alopecia Areata (1) · COVID-19 (1) · Idiopathic Pulmonary Fibrosis (1) · Myelodysplastic Syndromes (1) · Myeloproliferative Disorders (1) · Pneumonia (1) · Spondylitis, Ankylosing (1)
Suzhou Zelgen Biopharmaceuticals Co.,Ltd (9) · First Affiliated Hospital of Zhejiang University (1) · Nanfang Hospital, Southern Medical University (1)
China (11)
Chunde Bao, MD (1) · Jason Wu (1) · Jianya Zhou (1) · Jie Jin, MD (1) · Qianjin Lu (1) · Qianjin Lu, PhD (1) · Xinghua Gao, PhD (1) · Yongping Song, PhD (1)